T. Jackson

Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic

Parijatham S. Thomas, L. Strong, B. Amini, 2018, Familial Cancer.

Survival of patients in a Phase 1 clinic

R. Kurzrock, A. Naing, D. Hong, 2009, Cancer.

Effect of the RET Inhibitor Vandetanib in a Patient With RET Fusion-Positive Metastatic Non-Small-Cell Lung Cancer.

P. Stephens, V. Miller, N. Ordóñez, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers

R. Kurzrock, G. Garcia-Manero, F. Janku, 2014, Cancer Chemotherapy and Pharmacology.

Survival of patients in a phase I clinic: The M. D. Anderson Cancer Center experience

R. Kurzrock, D. Hong, J. Wheler, 2008 .

Effect of the RET Inhibitor Vandetanib in a Patient With RET Fusion-Positive Metastatic Non-Small-Cell Lung Cancer.

P. Stephens, V. Miller, N. Ordóñez, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic

Parijatham S. Thomas, L. Strong, B. Amini, 2017, Familial Cancer.